Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fearon

Showing results (11-20 of 239) with videos related to

Pageof 24
Sort By:
QJM : Monthly Journal of the Association of Physicians|March 1, 1995
The B lymphocyte as an immunotherapeutic targetD T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1977
Purification of C3b inactivator and demonstration of its two polypeptide chain structureD T Fearon
Seminars in Immunology|November 4, 1998
The complement system and adaptive immunityD T Fearon
Advances in Immunology|November 6, 2007
The expansion and maintenance of antigen-selected CD8(+) T cell clonesDouglas T Fearon
Science (New York, N.Y.)|March 17, 1995
Through the glass lightlyD T Fearon
The New England Journal of Medicine|February 26, 1976
Editorial: Glomerulonephritis, complement and C3NeFD T Fearon
Nature Immunology|March 15, 2001
Innate immunity--beginning to fulfill its promise?D T Fearon
Science (New York, N.Y.)|March 17, 1995
Through the glass lightlyD T Fearon
Advances in Experimental Medicine and Biology|January 16, 1999
Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22D T Fearon
Current Opinion in Immunology|June 1, 1993
The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytesD T Fearon
Pageof 24

Showing results (11-20 of 239) with videos related to

Sort By:
Pageof 24
QJM : Monthly Journal of the Association of Physicians|March 1, 1995
The B lymphocyte as an immunotherapeutic targetD T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1977
Purification of C3b inactivator and demonstration of its two polypeptide chain structureD T Fearon
Seminars in Immunology|November 4, 1998
The complement system and adaptive immunityD T Fearon
Advances in Immunology|November 6, 2007
The expansion and maintenance of antigen-selected CD8(+) T cell clonesDouglas T Fearon
Science (New York, N.Y.)|March 17, 1995
Through the glass lightlyD T Fearon
The New England Journal of Medicine|February 26, 1976
Editorial: Glomerulonephritis, complement and C3NeFD T Fearon
Nature Immunology|March 15, 2001
Innate immunity--beginning to fulfill its promise?D T Fearon
Science (New York, N.Y.)|March 17, 1995
Through the glass lightlyD T Fearon
Advances in Experimental Medicine and Biology|January 16, 1999
Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22D T Fearon
Current Opinion in Immunology|June 1, 1993
The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytesD T Fearon
Pageof 24